Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-11 | New | $1,176,300 | $1,176,300 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Benjamin Anderson | Director |
| Eric Ladizinsky | Director |
| Andrew Nappin | Executive |
| Stuart E. Siegel | Director |
| Janusz Maria Sowadski | Director |
| Thomas M. Wheeler | Director |